Stockscreener 앱 받기
22.52
1.49%
0.33
시간 외 거래:
22.52
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
Two new option listings and one option delisting on November 21st - TipRanks
LMR Partners LLP Reduces Stock Holdings in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
(RAPP) Investment Analysis and Advice - Stock Traders Daily
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 6.5% – Should You Sell? - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 6.5%Time to Sell? - MarketBeat
Cormorant Asset Management's Strategic Acquisition in Rapport Th - GuruFocus.com
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting - GlobeNewswire
Rapport Therapeutics to Present Phase 2a Epilepsy Drug Data at Major Conference | RAPP Stock News - StockTitan
FMR LLC's Strategic Acquisition in Rapport Therapeutics Inc - GuruFocus.com
Cartesian Therapeutics (NASDAQ:RNAC) & Rapport Therapeutics (NASDAQ:RAPP) Head to Head Comparison - Defense World
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates - MSN
(RAPP) Investment Report - Stock Traders Daily
Rapport Therapeutics Inc (RAPP) Quarterly 10-Q Report - Quartzy
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update - The Manila Times
Rapport (RAPP) Hit With FDA Hold Despite $320M Cash Position; Q3 Loss Widens | RAPP Stock News - StockTitan
Rapport Therapeutics to Present at Stifel Healthcare - GlobeNewswire
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November - StockTitan
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up – Still a Buy? - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat
SG Americas Securities LLC Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
(RAPP) Trading Report - Stock Traders Daily
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 4.2%Here's Why - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap DownShould You Sell? - MarketBeat
Jones Trading Initiates Coverage of Rapport Therapeutics (RAPP) with Buy Recommendation - MSN
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 2.7%Time to Sell? - MarketBeat
This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - MSN
When (RAPP) Moves Investors should Listen - Stock Traders Daily
Rapport Therapeutics (NASDAQ:RAPP) Sets New 1-Year HighTime to Buy? - MarketBeat
Millennium Management LLC Makes New $2.72 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Short Interest Up 32.4% in September - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.3%What's Next? - MarketBeat
75,516 Shares in Rapport Therapeutics (NASDAQ:RAPP) Purchased by The Manufacturers Life Insurance Company - MarketBeat
Two more Mass. biotechs raise $330M in IPOs, to debut on Nasdaq - The Business Journals
(RAPP) On The My Stocks Page - Stock Traders Daily
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 7%Should You Buy? - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 4.1% - MarketBeat
Logos Global Management LP Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Perceptive Advisors LLC Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 6.2% Higher - MarketBeat
GC Therapeutics: $65 Million (Series A) Raised To Unlock The Next Generation Of Cell Therapy-Based Medicines - Pulse 2.0
(RAPP) Technical Data - Stock Traders Daily
ARCH Venture Management LLC Makes New $86.73 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
ARCH Venture Management LLC Invests $86.73 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
GC Therapeutics Raises $65M Series A - citybiz
Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans - The Business Journals
Rapport Therapeutics Inc. (RAPP) rating initates by TD Cowen - Knox Daily
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 2.4% - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 4.7% - Defense World
GC Therapeutics Announces Launch Scale and Unlock the Next Generation of Cell Therapy - citybiz
Reckitt shares up on report of potential homecare asset sale By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright - TipRanks
Quest Partners LLC Sells 5,882 Shares of iRobot Co. (NASDAQ:IRBT) - Defense World
Sofinnova Investments Inc. Invests $45.39 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 4.7% Higher - MarketBeat
RNAZ’s Financial Health: Exploring TransCode Therapeutics Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
Trimble and Platform Science pushed hard to get deal done before Vegas meeting - Yahoo Finance
0.93%
3.55%
자본화:
|
볼륨(24시간):